5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth
The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.
Read MoreThe findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.
Read MoreGynecologic oncologists at the Dan L Duncan Comprehensive Cancer Center answer common questions about ovarian cancer risk factors and screening.
Read MoreWhile ovarian cancer is considered to be a relatively rare disease, it is also the most lethal gynecologic cancer, causing more deaths than any other
Read MoreIn her lab at Baylor College of Medicine, Dr. JoAnn Richards, Dr. Achuth Padmanabhan, instructor of molecular and cell biology and their colleagues are exploring new ways to
Read MoreOvarian cancer is currently treated with surgery and chemotherapy. Chemotherapy for ovarian cancer is based on drugs that act on any cell that is rapidly
Read MoreWant to have a fun, dynamic workout while supporting a great cause? Sign up for our women’s cancer fundraiser, Spin for Gyn! The indoor spin-cycling fundraising
Read MoreIn January 2015, at the urging of my friend of 40 years, a retired OB/GYN, I finally went to see an internist about a pain
Read MoreOften referred to as the “silent killer,” ovarian cancer‘s mild symptoms can go undiagnosed in its early stages. Dr. Marian Yvette Williams-Brown, assistant professor of
Read MoreIn the last two years, actress Angelina Jolie—an identified carrier of a genetic mutation (BRCA) that significantly increases her risk for developing breast and ovarian
Read More